Booster dose will protect against Omicron: The third dose of the vaccine is 88% effective against Omicron, the second dose becomes 50% ineffective only after 6 months

A third dose of existing vaccines of the corona virus can increase our immunity against the Omicron variant by up to 88%. This claim has been made in a recent research conducted in Britain. According to the report of the UK Health Security Agency (UKHSA), its effect decreases by 52% after 6 months of taking the second dose. Therefore, it is necessary to have a booster dose to avoid corona infection and severe symptoms.

Booster dose prevents hospitalization when on Omicron

The UKHSA report clearly states that the booster dose is less effective on Omicron than the Delta variant. However, it does protect patients from severe symptoms that can lead to hospitalization when administered on Omicron. Recently, British Prime Minister Boris Johnson had told that 90% of corona victims admitted to the country’s ICUs have not received a booster dose.

The effectiveness of the vaccine increases from 52% to 88% after the third dose.

According to the report, the effectiveness of the vaccine increases from 52% to 88% after the third dose. The cases of Omicron do not become serious after the third dose of vaccine. People have few or no symptoms. The risk of hospitalization of such patients is also reduced by 81%. Children in the age group of 5 to 17 years also survive hospitalization.

Researchers say that patients with Omicron’s symptoms are 68% less likely to be hospitalized after receiving a booster dose.

Even two doses of Coveshield are not effective against Omicron.

It has been revealed in the study that even two doses of Coveshield applied in India are not effective against Omicron. The immunity against corona in the body decreases within 5 months after the second dose of Covishield. At the same time, increased immunity from the second dose of Pfizer and Moderna comes down to 70% to 10% after 6 months.